Literature DB >> 20010799

The mousepox experience. An interview with Ronald Jackson and Ian Ramshaw on dual-use research. Interview by Michael J. Selgelid and Lorna Weir.

Ronald Jackson, Ian Ramshaw.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 20010799      PMCID: PMC2816623          DOI: 10.1038/embor.2009.270

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  5 in total

1.  Responsible conduct by life scientists in an age of terrorism.

Authors:  Ronald M Atlas
Journal:  Sci Eng Ethics       Date:  2009-05-07       Impact factor: 3.525

2.  Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.

Authors:  R J Jackson; A J Ramsay; C D Christensen; S Beaton; D F Hall; I A Ramshaw
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  The efficacy of cidofovir treatment of mice infected with ectromelia (mousepox) virus encoding interleukin-4.

Authors:  Samantha J Robbins; Ronald J Jackson; Frank Fenner; Sandra Beaton; Jill Medveczky; Ian A Ramshaw; Alistair J Ramsay
Journal:  Antiviral Res       Date:  2005-01-25       Impact factor: 5.970

4.  Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome.

Authors:  Daniel G Gibson; Gwynedd A Benders; Cynthia Andrews-Pfannkoch; Evgeniya A Denisova; Holly Baden-Tillson; Jayshree Zaveri; Timothy B Stockwell; Anushka Brownley; David W Thomas; Mikkel A Algire; Chuck Merryman; Lei Young; Vladimir N Noskov; John I Glass; J Craig Venter; Clyde A Hutchison; Hamilton O Smith
Journal:  Science       Date:  2008-01-24       Impact factor: 47.728

5.  Recombinant vaccinia virus coexpressing the F protein of respiratory syncytial virus (RSV) and interleukin-4 (IL-4) does not inhibit the development of RSV-specific memory cytotoxic T lymphocytes, whereas priming is diminished in the presence of high levels of IL-2 or gamma interferon.

Authors:  G P Bembridge; J A Lopez; R Cook; J A Melero; G Taylor
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

  5 in total
  6 in total

1.  The responsibility of the scientist. What can history teach us about how scientists should handle research that has the potential to create harm?

Authors:  Peter Herrlich
Journal:  EMBO Rep       Date:  2013-08-13       Impact factor: 8.807

2.  Data sharing and dual-use issues.

Authors:  Louise Bezuidenhout
Journal:  Sci Eng Ethics       Date:  2011-07-30       Impact factor: 3.525

3.  The ethics of biosafety considerations in gain-of-function research resulting in the creation of potential pandemic pathogens.

Authors:  Nicholas Greig Evans; Marc Lipsitch; Meira Levinson
Journal:  J Med Ethics       Date:  2015-08-28       Impact factor: 2.903

4.  Dual-use decision making: relational and positional issues.

Authors:  Nicholas G Evans
Journal:  Monash Bioeth Rev       Date:  2014 Sep-Dec

5.  Information Hazards in Biotechnology.

Authors:  Gregory Lewis; Piers Millett; Anders Sandberg; Andrew Snyder-Beattie; Gigi Gronvall
Journal:  Risk Anal       Date:  2018-11-12       Impact factor: 4.000

Review 6.  Synthetic constructs in/for the environment: managing the interplay between natural and engineered Biology.

Authors:  Markus Schmidt; Víctor de Lorenzo
Journal:  FEBS Lett       Date:  2012-02-23       Impact factor: 4.124

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.